Paul A. Zappala »

Takeda Pharmaceutical shares owned by Paul A. Zappala

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Paul A. Zappala from 13F filings

Historical chart of Paul A. Zappala investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Paul A. Zappala consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Paul A. Zappala

Quarter filed Position value Share count Share price at filing
2019-03-31 $999 30 33.33

More positions owned by Paul A. Zappala

Vanguard European ETF (VGK)
Schwab Emerging Markets Equity ETF (SCHE)
IQ Hedge Multi-Strategy Tracker (QAI)
Vanguard Pacific ETF (VPL)
SPDR S&P MidCap 400 ETF (MDY)
Ishares Core Msci Eafe Etf core msci eafe (IEFA)
iShares S&P SmallCap 600 Index (IJR)
Schwab International Equity ETF (SCHF)
iShares S&P MidCap 400 Growth (IJK)
Vanguard Information Technology ETF (VGT)
Health Care SPDR (XLV)
iShares S&P 500 Growth Index (IVW)
Microsoft Corporation (MSFT)
iShares MSCI Canada Index (EWC)
Invesco Exchange Traded Fd T s&p500 eql fin (RSPF)

View all positions for Paul A. Zappala

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Millennium Management
Brandes Investment Partners
Renaissance Technologies
First Trust Advisors
FMR
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management

View all funds holding Takeda Pharmaceutical